Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning (Allergen) - Taza brand Chat Papdi - Gram Flour Snack recalled due to undeclared wheat


Product photo is available: https://inspection.gc.ca/eng/1574459968758/1574459969195

OTTAWA, Nov. 22, 2019 /CNW/ - The food recall warning issued on November 7, 2019 has been updated to include additional distribution information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Taza Food Products Ltd. is recalling Taza brand Chat Papdi ? Gram Flour Snack from the marketplace because it contains wheat which is not declared on the label. People who have an allergy to wheat, or have celiac disease or other gluten-related disorders should not consume the recalled product described below.

The following product has been sold in Ontario and Quebec.

Recalled product

 

Brand

Product

Size

UPC

Codes

Taza

Chat Papdi ? Gram Flour Snack

360 g

8 96546 00089 1

All units sold up to and including November 7, 2019

 

What you should do

Check to see if you have the recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to wheat, or have celiac disease or other gluten-related disorders, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by a consumer complaint. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of this product.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...



News published on and distributed by: